Effect of edaravone on serum SP-A and arterial blood gas in patients with lobectomy

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 6, 2015, Pages 10021-10025

  Song, Li ^a   Xiong, Feng ^b   Zhang, Xue Juan ^a   Liu, Wei Yi ^a   Zhao, Yang ^a   Feng, Wei ^a  

^a QINGDAO UNIVERSITY   (China)

^b Department of Neurosurgery Rizhao People s Hospital   (China)

Author keywords

ABG analysis; Edaravone; Lung ventilation; SP A

Indexed keywords

NORPHENAZONE; SURFACTANT PROTEIN A;

ACUTE LUNG INJURY; ADULT; ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTRACHEAL INTUBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART RATE; HUMAN; LOBECTOMY; LUNG CANCER; LUNG VENTILATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; OXYGEN SATURATION; SKIN INCISION; VEIN CATHETERIZATION;

EID: 84938327742     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Li C and Hong W. Research status and funding trends of lung cancer biomarkers. J Thorac Dis 2013; 5: 698-705.
2. Krueger T, Perentes JY, Peters S, Ris HB and Gonzalez M. [VATS lobectomy for early-stage primary lung cancer]. Rev Med Suisse 2012; 346: 1337-1341.
3. Zhao B, Zhang HR, Li HM and Li L. Mechanical ventilation associated lung injury in rats with pulmonary groups weave the relationship between cell apoptosis. Chinese Journal of Practical Medicine 2011; 50-52.
4. You ZJ, Xu HX and Zhou ZC. Different time of single lung ventilation effect on lung oxidatie stress level. Chinese General Practice 2010; 1492-1493.
5. Kapoor S. Neuroprotective effects of edaravone: Recent insights. J Neuro Sci 2013; 331: 177.
6. Kikuchi K, Takeshige N, Miura N, Morimoto Y, Ito T, Tancharoen S, Miyata K, Kikuchi C, Iida N, Uchikado H, Miyagi N, Shiomi N, Kuramoto T, Maruyama I, Morioka M and Kawahara KI. Beyond free radical scavenging: Beneficial effects of edaravone (Radicut) in various diseases (Review). Exp Ther Med 2012; 3: 3-8.
7. He WS, Hu Y, Zhang J, Jiang W, Li X and Chen L. Note in advance according to the adr of single lung ventilation opening in the process of the lateral thoracic collapsed lung TNF alpha, the change of IL-6 and IL-10. The Journal of Clinical Anesthesiology 2012; 28: 875-877.
8. Wang Y, Qu YY, Song ZX and Jia HQ. In accordance with edaravone in advance to the influence of lung injury in patients with single lung ventilation. Chinese Journal of Anesthesiology 2010; 30: 661-663.
9. Ren Y, Gao W, Cui XG and Li DM. One-lung ventilation atelectatic lung injury mechanism of the research. International Magazine of Anaesthesia and Recovery 2013; 34: 834-836.
10. Sugasawa Y, Yamaguchi K, Kumakura S, Murakami T, Kugimiya T, Suzuki K, Nagaoka I and Inada E. The effect of one-lung ventilation upon pulmonary inflammatory responses during lung resection. J Anesth 2011; 25: 170-177.
11. Liu MX, Ren FY, He LY, Wang Y, Xu HM. One-Lung ventilation mode different lung injury in patients with esophageal cancer surgery. Shandong Med 2013; 53: 20-22.
12. McCormack FX, Whitsett JA. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 2002; 109: 707-712.
13. Wu Y, Adam S, Hamann L, Heine H, Ulmer AJ, Buwitt-Beckmann U, Stamme C. Accumulation of inhibitory kappaB-alpha as a mechanism contributing to the anti-inflammatory effects of surfactant protein-A. Am J Respir Cell Mol Biol 2004; 31: 587-594.
14. zhang XM, Chen HL. A protein involved in lung surface active substances in the acute lung injury. Chinese and Western Medicine Combined with Surgical Magazine in China 2010; 16: 720-722.
15. Takahashi H, Sano H, Chiba H and Kuroki Y. Pulmonary surfactant proteins A and D: innate immune functions and biomarkers for lung diseases. Curr Pharm Des 2006; 12: 589-598.
16. Chen F, Shu XM, Wang DX, Xie Y and Wang GC. Surfactant proteins-A and D as important serum markers for interstitial lung disease in patients with polymyositis or dermatomyositis. Zhonghua Yi Xue Za Zhi 2012; 92: 2182-2185.
17. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD and Rodriguez-Roisin R. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-365.